Welcome!

News Feed Item

Arterial Calcification Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Arterial Calcification Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

Arterial Calcification Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Arterial Calcification Global Clinical Trials Review, H2, 2014" provides data on the Arterial Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Calcification. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arterial Calcification. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 5
Arterial Calcification 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Arterial Calcification Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Medestea Internazionale S.p.A. 27
Clinical Trial Overview of Medestea Internazionale S.p.A. 27
Amgen Inc. 28
Clinical Trial Overview of Amgen Inc. 28
Clinical Trial Overview of Top Institutes / Government 29
National Heart, Lung, and Blood Institute 29
Clinical Trial Overview of National Heart, Lung, and Blood Institute 29
Medical University of Lodz 30
Clinical Trial Overview of Medical University of Lodz 30
Romanian Society of Nephrology 31
Clinical Trial Overview of Romanian Society of Nephrology 31
Okayama University 32
Clinical Trial Overview of Okayama University 32
Kingston General Hospital 33
Clinical Trial Overview of Kingston General Hospital 33
Osaka University 34
Clinical Trial Overview of Osaka University 34
Aarhus University 35
Clinical Trial Overview of Aarhus University 35
Mayo Clinic in Rochester 36
Clinical Trial Overview of Mayo Clinic in Rochester 36
National Taiwan University Hospital 37
Clinical Trial Overview of National Taiwan University Hospital 37
University of Kentucky 38
Clinical Trial Overview of University of Kentucky 38
Five Key Clinical Profiles 39
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68

List of Tables

Arterial Calcification Therapeutics, Global, Clinical Trials by Region, 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Arterial Calcification Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medestea Internazionale S.p.A., 2014* 27
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 28
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 29
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Lodz, 2014* 30
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Romanian Society of Nephrology, 2014* 31
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2014* 32
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Kingston General Hospital, 2014* 33
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 34
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 35
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic in Rochester, 2014* 36
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 37
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 38

List of Figures

Arterial Calcification Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 67

To order this report: Arterial Calcification Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
SYS-CON Events announced today that Linux Academy, the foremost online Linux and cloud training platform and community, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Linux Academy was founded on the belief that providing high-quality, in-depth training should be available at an affordable price. Industry leaders in quality training, provided services, and student certification passes, its goal is to c...
Some people worry that OpenStack is more flash then substance; however, for many customers this could not be farther from the truth. No other technology equalizes the playing field between vendors while giving your internal teams better access than ever to infrastructure when they need it. In his session at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will talk through some real-world OpenStack deployments and look into the ways this can benefit customers of all sizes....
Deep learning has been very successful in social sciences and specially areas where there is a lot of data. Trading is another field that can be viewed as social science with a lot of data. With the advent of Deep Learning and Big Data technologies for efficient computation, we are finally able to use the same methods in investment management as we would in face recognition or in making chat-bots. In his session at 20th Cloud Expo, Gaurav Chakravorty, co-founder and Head of Strategy Development ...
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Interoute has announced the integration of its Global Cloud Infrastructure platform with Rancher Labs’ container management platform, Rancher. This approach enables enterprises to accelerate their digital transformation and infrastructure investments. Matthew Finnie, Interoute CTO commented “Enterprises developing and building apps in the cloud and those on a path to Digital Transformation need Digital ICT Infrastructure that allows them to build, test and deploy faster than ever before. The int...
In his session at @ThingsExpo, Eric Lachapelle, CEO of the Professional Evaluation and Certification Board (PECB), will provide an overview of various initiatives to certifiy the security of connected devices and future trends in ensuring public trust of IoT. Eric Lachapelle is the Chief Executive Officer of the Professional Evaluation and Certification Board (PECB), an international certification body. His role is to help companies and individuals to achieve professional, accredited and worldw...
SYS-CON Events announced today that Loom Systems will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2015, Loom Systems delivers an advanced AI solution to predict and prevent problems in the digital business. Loom stands alone in the industry as an AI analysis platform requiring no prior math knowledge from operators, leveraging the existing staff to succeed in the digital era. With offices in S...
What if you could build a web application that could support true web-scale traffic without having to ever provision or manage a single server? Sounds magical, and it is! In his session at 20th Cloud Expo, Chris Munns, Senior Developer Advocate for Serverless Applications at Amazon Web Services, will show how to build a serverless website that scales automatically using services like AWS Lambda, Amazon API Gateway, and Amazon S3. We will review several frameworks that can help you build serverle...
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...
The Software Defined Data Center (SDDC), which enables organizations to seamlessly run in a hybrid cloud model (public + private cloud), is here to stay. IDC estimates that the software-defined networking market will be valued at $3.7 billion by 2016. Security is a key component and benefit of the SDDC, and offers an opportunity to build security 'from the ground up' and weave it into the environment from day one. In his session at 16th Cloud Expo, Reuven Harrison, CTO and Co-Founder of Tufin, ...
SYS-CON Events announced today that T-Mobile will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on ...
SYS-CON Events announced today that HTBase will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. HTBase (Gartner 2016 Cool Vendor) delivers a Composable IT infrastructure solution architected for agility and increased efficiency. It turns compute, storage, and fabric into fluid pools of resources that are easily composed and re-composed to meet each application’s needs. With HTBase, companies can quickly prov...